Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of …

Y Nishimura, DC Fajgenbaum… - American Journal of …, 2021 - Wiley Online Library
Thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly
(TAFRO) syndrome is a heterogeneous entity manifesting with a constellation of symptoms …

TAFRO syndrome: A severe manifestation of Sjogren's syndrome? A systematic review

L Grange, E Chalayer, D Boutboul, S Paul… - Autoimmunity …, 2022 - Elsevier
Background Sjögren's syndrome (SjS) is a systemic autoimmune disease characterized by
lymphocytic infiltration of the salivary and lacrimal glands associated with sicca syndrome …

[HTML][HTML] TAFRO syndrome is associated with anti-SSA/Ro60 antibodies, in contrast to idiopathic castleman disease

M Shirakashi, Y Nishida, R Nakashima, M Fujimoto… - Scientific Reports, 2024 - nature.com
TAFRO syndrome is an acute systemic inflammatory disease characterized by
thrombocytopenia, anasarca, fever, reticulin fibrosis/renal dysfunction, and organomegaly …

[HTML][HTML] Sepsis-associated disseminated intravascular coagulation and its differential diagnoses

T Iba, E Watanabe, Y Umemura, T Wada… - Journal of intensive …, 2019 - Springer
Disseminated intravascular coagulation (DIC) is a common complication in sepsis. Since
DIC not only promotes organ dysfunction but also is a strong prognostic factor, its diagnosis …

[HTML][HTML] Multicentric Castleman disease and the evolution of the concept

T Zhou, HW Wang, S Pittaluga, ES Jaffe - Pathologica, 2021 - ncbi.nlm.nih.gov
The term multicentric Castleman disease (MCD) encompasses a spectrum of conditions that
share some overlapping clinicopathological manifestations. The fundamental pathogenetic …

Optimal treatments for TAFRO syndrome: a retrospective surveillance study in Japan

S Fujimoto, H Kawabata, T Sakai… - International journal of …, 2021 - Springer
TAFRO syndrome is a systemic inflammatory disorder of unknown etiology characterized by
thrombocytopenia, anasarca, fever, reticulin myelofibrosis, renal dysfunction, and …

International definition of iMCD-TAFRO: future perspectives

Y Nishimura, MF Nishimura, Y Sato - Journal of clinical and …, 2022 - jstage.jst.go.jp
Since thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and
organomegaly (TAFRO) syndrome was first proposed in 2010, there has been considerable …

[HTML][HTML] Renal pathologic findings in TAFRO syndrome: is there a continuum between thrombotic microangiopathy and membranoproliferative glomerulonephritis? A …

A Leurs, V Gnemmi, A Lionet, L Renaud… - Frontiers in …, 2019 - frontiersin.org
Background: TAFRO syndrome is a clinical subtype of idiopathic multicentric Castleman
disease (iMCD) that is characterized by thrombocytopenia, anasarca, fever and/or elevated …

TAFRO syndrome: A disease that known is half cured

T Chen, C Feng, X Zhang, J Zhou - Hematological Oncology, 2023 - Wiley Online Library
Thrombocytopenia, anasarca, fever, reticulin fibrosis/renal failure, and organomegaly
(TAFRO) syndrome is rare in clinical practice. It is a systemic inflammatory disease caused …

Tocilizumab for the treatment of TAFRO syndrome: a systematic literature review

M Akiyama, Y Kaneko, T Takeuchi - Annals of Hematology, 2020 - Springer
TAFRO syndrome is a newly recognized disease entity characterized by thrombocytopenia,
anasarca, fever, reticulin myelofibrosis, renal dysfunction, and organomegaly. The objective …